Skip to content
Skip to content

Does CoQ10 help migraine frequency? (Grade B evidence)

Explore current source-reported research for this exact question. These records are separate from the synthesis below; they do not update its grade or establish a recommendation.

For migraine frequency, CoQ10 carries Grade B evidence: probably helps, moderate certainty, especially in adults with episodic migraine, prophylaxis; effect size may shrink with better trials. Dose range commonly 300 mg/day in the trials.

Exact question reviewed

Population
adults with episodic migraine, prophylaxis
Intervention
CoQ10 · commonly 300 mg/day in the trials
Comparator
not reported
Outcome
migraine frequency
Time horizon
not reported

Bottom line. For migraine frequency, CoQ10 carries Grade B evidence: probably helps, moderate certainty, especially in adults with episodic migraine, prophylaxis; effect size may shrink with better trials. Dose range commonly 300 mg/day in the trials. [1 SR/meta]

Direction
benefit
Magnitude
Meta-analysis of RCTs: CoQ10 supplementation reduced migraine attack frequency (and, in some trials, duration) versus placebo; effect on migraine severity was less consistent. Trials are relatively small, so certainty is moderate rather than high.
Grade
B
Certainty
moderate
Clinical meaning
small but potentially useful
Who it applies to
adults with episodic migraine, prophylaxis
Dose / form studied
commonly 300 mg/day in the trials
Safety
not assessed
The one limitation
Claim-specific limitation details are not available in this public record.

Reviewed not reported · Evidence last changed · Open evidence record (version 0)

Grade
B
what does the grade mean?
Certainty
moderate
what does certainty mean?

Grade B / moderate: probably helps, and new studies are unlikely to reverse this — but could shrink the effect size.

Who it works for

Best-studied in adults with episodic migraine, prophylaxis. Recorded studied dose: commonly 300 mg/day in the trials.

Evidence

StudyDesignRoleCite
Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis.peer-reviewedsupportsPMID:33402403

Why this grade

Reasoning trace

The current record stores Grade B at moderate certainty and links 1 publishable source. A claim-specific domain-by-domain grading rationale is not available in this public record, so no reason for upgrading or downgrading is inferred here.

Audit and version

Claim ID
ec_b4-coq10-migraine
Claim version
not reported
Governance
legacy, not verified
Clinician review
Not yet reviewed by a licensed clinician
Last evidence search
not reported
Last editorial review
not verified

Public receipt · Machine-readable claim · Methodology

Dose & form

Studied intake: commonly 300 mg/day in the trials.

How it stacks up for migraine frequency

Grade history

No grade changes yet. Initial grade assigned; re-reviewed on every 12 months (Grade A/B). Methodology v1.

Re-review cadence: every 12 months (Grade A/B) · methodology v1.

Frequently asked

How long does CoQ10 take to work for migraine frequency?

This record does not report a studied onset time for CoQ10 and migraine frequency. Do not assume a typical timeframe.

What dose was used in studies of CoQ10 for migraine frequency?

The recorded studied dose for CoQ10 and migraine frequency is commonly 300 mg/day in the trials. This is a source detail, not a dose recommendation.

Does CoQ10 work for migraine frequency if I'm not deficient?

The recorded studied population is adults with episodic migraine, prophylaxis. This field alone does not show whether deficiency or baseline status changes the effect.

CoQ10 or the next-best alternative for migraine frequency?

See the compare block above for the head-to-head with the most-cited alternative. Grade + certainty differences matter more than any single trial.

Related

What this is — and is not

Evidence description
Meta-analysis of RCTs: CoQ10 supplementation reduced migraine attack frequency (and, in some trials, duration) versus placebo; effect on migraine severity was less consistent. Trials are relatively small, so certainty is moderate rather than high.
Substrate's interpretation
The current reviewed record assigns Grade B at moderate certainty. A domain-by-domain rationale is shown only when recorded.
Discuss with a clinician
If you're on medication or have a condition that changes the calculus, bring the interaction & population blocks above to your pharmacist or prescriber before deciding.
Individualized medical advice
Not provided here or on any Substrate surface (API, agent tool, embed) — see YMYL policy.

Cite this page

Citation is encouraged. The proposed reuse license is CC-BY-4.0; status: pending-governance-ratification.

Plain-text citation
Substrate. Does CoQ10 help migraine frequency? (Grade B). https://evidencebased.info/interventions/coq10/migraine. Updated 2026-07-16.
BibTeX
@misc{substrate_entionscoq10migraine,
  author = {Substrate editorial},
  title  = {Does CoQ10 help migraine frequency?},
  year   = {2026},
  url    = {https://evidencebased.info/interventions/coq10/migraine},
  note   = {Grade B, evidencebased.info}
}

Found something wrong on this page? Report an error →

Current source-reported research

Membership uses admitted intervention and measured-outcome associations for this exact question. Different populations, preparations, comparators and timepoints remain separate. No pooling or update to the synthesis is asserted.